Related references
Note: Only part of the references are listed.Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma
Grigory Karmazanovsky et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors
Aura D. Herrera-Martinez et al.
ENDOCRINE-RELATED CANCER (2019)
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
Giulia Bresciani et al.
ENDOCRINE CONNECTIONS (2019)
Analysis of radiation effects in two irradiated tumor spheroid models
Afkar Al-Ramadan et al.
ONCOLOGY LETTERS (2018)
LMTK3 confers chemo-resistance in breast cancer
Justin Stebbing et al.
ONCOGENE (2018)
Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro
Tracey Hurrell et al.
TOXICOLOGY IN VITRO (2018)
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
Sigrid A. Langhans
FRONTIERS IN PHARMACOLOGY (2018)
Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study
S. Faivre et al.
ANNALS OF ONCOLOGY (2017)
Dual modulation of MCL-1 and mTOR determines the response to sunitinib
Mohamed Elgendy et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
Anja Rinke et al.
NEUROENDOCRINOLOGY (2017)
Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism
Tabea Wiedmer et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Diagnostic value of chromogranin A in pancreatic neuroendocrine tumors depends on tumor size: A prospective observational study from a single institute
Eunsung Jun et al.
SURGERY (2017)
Radionuclide Therapy for Neuroendocrine Tumors
Mauro Cives et al.
CURRENT ONCOLOGY REPORTS (2017)
Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening
Robson L. F. Amaral et al.
FRONTIERS IN PHYSIOLOGY (2017)
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors
Nicola Fazio et al.
JOURNAL OF THORACIC DISEASE (2017)
Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
Joo Young Kim et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
Mauro Cives et al.
DRUGS (2015)
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
Rasheena Edmondson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
3D tumor models: history, advances and future perspectives
Parul Benien et al.
FUTURE ONCOLOGY (2014)
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin et al.
DRUG DISCOVERY TODAY (2013)
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Chung Wong et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors
Daniela Mole et al.
ENDOCRINE-RELATED CANCER (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses
Daniel J. Maltman et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Activity of sunitinib in patients with advanced neuroendocrine tumors
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
Paraic A. Kenny et al.
MOLECULAR ONCOLOGY (2007)
Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types
JM Kelm et al.
BIOTECHNOLOGY AND BIOENGINEERING (2003)
Share Paper
